ABP140 Antibody

What is ABP140 and what is its primary function in yeast cells?

ABP140 is a 71 kDa protein found in Saccharomyces cerevisiae (budding yeast) that contains a short N-terminal actin-binding motif (residues 1-17) known as Lifeact and a C-terminal conserved methyltransferase domain (residues 244-627). The protein serves dual functions in yeast cells: it binds and weakly bundles actin filaments through its N-terminal domain, and its C-terminal domain mediates methylation of tRNAs . These seemingly unrelated functions are separated by a ribosomal frameshift site. ABP140 shows physical and genetic interactions with regulators of Rho GTPase activity, the septin ring, and factors involved in actin polymerization and stabilization, suggesting a potential role in actin dynamics .

How is ABP140 mRNA localized in yeast cells?

ABP140 mRNA is transported to the distal pole of budding yeast in a process dependent on actin. This localization occurs cotranslationally via actin retrograde flow, as part of a ternary complex comprising the mRNA, translating ribosomes, and nascent polypeptides. The actin-binding domain (ABD) of Abp140p is necessary but not sufficient for this localization. Studies have shown that the first 67 amino acids of Abp140p (including the ABD and an additional segment from amino acids 18-67) are required for proper mRNA localization to the distal pole .

What makes Lifeact (the actin-binding domain of ABP140) valuable for research?

Lifeact, the 17-amino acid actin-binding domain of ABP140, has become an important tool for visualizing F-actin structures in live cells. When fused to fluorescent proteins like mNeonGreen, Lifeact provides significant advantages over full-length ABP140-GFP. It more uniformly decorates actin patches and cables in both mother and bud compartments of yeast cells, whereas full-length ABP140-GFP shows reduced decoration in the bud. Lifeact-3xmNeonGreen provides up to 20-fold enhanced cable detection without altering cellular actin organization or dynamics, making it an excellent probe for visualizing various F-actin structures, including cables, patches, and the cytokinetic actomyosin ring .

How does the cotranslational transport of ABP140 mRNA work at the molecular level?

ABP140 mRNA transport occurs through a cotranslational mechanism involving actin retrograde flow. The model suggests that ABP140 mRNA is transported as part of a ternary complex consisting of the mRNA, translating ribosomes, and nascent Abp140p polypeptides. As translation occurs, the N-terminal actin-binding domains of the nascent Abp140p chains bind to actin cables. The actin retrograde flow then moves the entire complex toward the distal pole of the cell. This model is supported by experiments showing that translation inhibition with cycloheximide (which stabilizes the ternary complex) maintains distal pole localization, while translation inhibition with other methods that disrupt the ternary complex abolishes localization. Additionally, longer mRNAs that can accommodate more ribosomes enhance recruitment to cables because the sum of nascent peptides can bind actin with higher avidity .

What are potential approaches for generating specific antibodies against ABP140?

Generating specific antibodies against ABP140 could benefit from computational approaches that optimize antibody sequences for desired binding profiles. Recent advances in antibody engineering use a combination of phage display selections and computational modeling to design antibodies with customized specificity profiles. This approach involves identifying different binding modes associated with particular ligands and using biophysics-informed modeling to optimize antibody sequences. The method can generate either highly specific antibodies that interact with a single target ligand while excluding others or cross-specific antibodies that interact with multiple distinct ligands .

To design specific ABP140 antibodies, researchers could:

• Perform phage display selections with ABP140 domains

• Collect sequence data through high-throughput sequencing

• Build computational models that identify binding modes

• Optimize antibody sequences based on energy functions associated with each binding mode

• Validate the designed antibodies experimentally

What imaging approaches are optimal for visualizing ABP140-labeled actin structures?

For optimal visualization of actin structures using ABP140-based probes:

• Probe selection: Lifeact-3xmNeonGreen expressed from the endogenous ABP140 promoter provides significantly better results than full-length ABP140-GFP, with up to 20-fold enhancement in cable detection and improved signal-to-noise ratio .

• Expression level optimization: Expressing Lifeact at relatively low levels (from its native promoter) provides intense labeling of F-actin structures without the detrimental effects observed with overexpression. This approach avoids the stabilization of F-actin structures and disruption of actin-driven processes that can occur with overexpression .

• Live imaging considerations: When imaging live cells, consider:

  • Using spinning disk confocal microscopy for improved signal detection and reduced photobleaching

  • Optimizing exposure times to balance signal intensity with photobleaching

  • Including appropriate controls to ensure that the probe does not alter actin dynamics

• Comparative analysis: For studying specific actin structures like cables growing inward from the cell cortex or dynamically interacting with organelles (such as vacuoles), Lifeact-3xmNeonGreen provides superior detection compared to ABP140-GFP .

How can researchers validate that ABP140 antibodies are not affecting normal actin dynamics?

When using ABP140 antibodies or ABP140-derived probes in research, it's crucial to verify that these tools do not disrupt normal actin dynamics. Validation approaches include:

• Growth rate assessment: Compare growth rates of cells expressing ABP140 probes with wild-type cells to ensure that the probe does not impair normal cellular functions .

• Actin organization analysis: Examine fixed cells stained with phalloidin to compare actin organization in cells with and without the ABP140 probe .

• Dynamic measurements:

  • Measure actin patch lifetimes and movement rates

  • Assess actin cable retrograde flow rates

  • Evaluate the assembly and contraction of the cytokinetic actomyosin ring

  Any significant differences compared to control cells would indicate that the probe is interfering with actin dynamics .

• Functional assays: Perform functional assays specific to actin-dependent processes, such as endocytosis efficiency, polarized growth, or cytokinesis progression, to ensure these processes remain unaffected .

What controls should be included when studying ABP140 mRNA localization?

When investigating ABP140 mRNA localization, the following controls are essential:

• Actin dependency controls:

  • Use actin-disrupting drugs (e.g., Latrunculin A) to confirm that localization depends on intact actin structures

  • Employ N-terminal truncation mutants lacking the actin-binding domain to verify that actin binding is required for localization

• Translation dependency controls:

  • Use cycloheximide to stabilize translating ribosomes and verify maintenance of localization

  • Apply other translation inhibitors that disrupt the ternary complex to demonstrate loss of localization

• Protein expression controls:

  • Generate constructs with artificial 5' UTRs that prevent Abp140p expression while preserving the mRNA sequence to confirm that protein expression is required for mRNA localization

  • Verify protein expression through immunoblotting and mRNA levels through quantitative RT-PCR

• Ectopic localization tests:

  • Replace the actin-binding domain with sequences targeting other cellular structures (e.g., mitochondria or ER) to demonstrate that protein localization determines mRNA localization

  • Confirm colocalization using appropriate markers (e.g., ER markers like Sec63p-RFP or HDEL-GFP)

What are the key considerations for designing ABP140 fusion proteins for research applications?

When designing ABP140-derived fusion proteins for research:

This approach has successfully generated probes that dramatically improve live imaging detection of actin cables and patches without altering in vivo dynamics or cell growth, enabling visualization of previously undetectable actin structures .

How have recent studies enhanced our understanding of ABP140's dual functionality?

Recent research has illuminated the dual functionality of ABP140, particularly the independence of its actin-binding and methyltransferase activities. The N-terminal actin-binding domain (Lifeact) is conserved only among close relatives of budding yeast, while the C-terminal methyltransferase domain is more widely conserved and has been shown to mediate specific methylation of tRNAs . These domains are separated by a ribosomal frameshift site, suggesting they may have evolved independently and been joined through gene fusion .

Studies have also revealed that the actin-binding activity of ABP140 is not only important for its localization but also for the transport of its own mRNA, representing a unique example of a protein determining the localization of its encoding mRNA through direct interaction with the cytoskeleton .

What technical advances have improved the utility of ABP140-derived tools for actin visualization?

Technical advances in ABP140-derived tools for actin visualization include:

• The discovery that the 17-amino-acid Lifeact fragment provides superior decoration of actin structures compared to the full-length protein, particularly in the bud compartment of yeast cells .

• The development of Lifeact-3xmNeonGreen fusion proteins that provide dramatically enhanced signal intensity (up to 20-fold improvement) without disrupting actin dynamics or cell growth .

• The creation of integration vectors for expressing these improved probes, enabling stable expression at appropriate levels .

• The demonstration that these improved probes can reveal previously undetectable actin structures, such as cables growing inward from the cell cortex and dynamically interacting with organelles like vacuoles .

These advances have transformed our ability to visualize F-actin structures in live cells, offering new insights into actin dynamics and interactions with cellular components.

How can researchers address potential artifacts when using ABP140-based actin probes?

When using ABP140-based probes for actin visualization, researchers might encounter artifacts that can be addressed through the following approaches:

• Asymmetric decoration artifacts:

  • Problem: Full-length Abp140-GFP decorates actin structures asymmetrically, with reduced signal in the bud compartment

  • Solution: Use Lifeact-based probes (especially Lifeact-3xmNeonGreen) instead of full-length ABP140, as these provide more uniform decoration across cellular compartments

• Overexpression artifacts:

  • Problem: Overexpression of actin-binding probes can stabilize F-actin structures and disrupt actin-driven processes

  • Solution: Express probes from the endogenous ABP140 promoter rather than from strong exogenous promoters, which provides sufficient signal without disruption

• Signal-to-noise issues:

  • Problem: Poor signal-to-noise ratio can make subtle actin structures difficult to detect

  • Solution: Use tandem fluorescent proteins (e.g., 3xmNeonGreen) to enhance signal intensity while maintaining low expression levels

• Dynamics alteration concerns:

  • Problem: Concerns that probes might alter actin dynamics

  • Solution: Validate probe effects on actin dynamics by measuring patch lifetimes, cable flow rates, and through functional assays of actin-dependent processes

By implementing these solutions, researchers can minimize artifacts and obtain more reliable data when studying actin structures using ABP140-derived probes.